BridgeBio Pharma, Inc. (BBIO) › Cost of RevenueBridgeBio Pharma, Inc. (BBIO) — Cost of RevenueAnnual figures by period end, from SEC filings.2021-12-31: $3.11M2022-12-31: $3.43M2023-12-31: $2.45M2024-12-31: $3.88M2025-12-31: $20.96M$20.96M2021-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$20.96M+440.5%2026-02-24From 2025-01-012024-12-31$3.88M+58.5%2026-02-24From 2024-01-012023-12-31$2.45M-28.8%2026-02-24From 2023-01-012022-12-31$3.43M+10.3%2025-02-20From 2022-01-012021-12-31$3.11M—2024-02-22From 2021-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)